US Stock MarketDetailed Quotes

Altamira Therapeutics Ltd (CYTOF)

Watchlist
  • 0.0501
  • 0.00000.00%
15min DelayClose Jul 24 15:51 ET
286.35KMarket Cap-0.04P/E (TTM)

Altamira Therapeutics Ltd (CYTOF) Cash Flow

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2018/Q4
2018/Q3
2018/Q2
2018/Q1
2017/Q4
2017/Q3
2017/Q2
2017/Q1
2016/Q4
2016/Q3
2016/Q2
2016/Q1
2015/Q4
2015/Q3
2015/Q2
2015/Q1
2014/Q4
2014/Q3
2014/Q2
2014/Q1
Operating Cash Flow
+71.02%-1.92M
+8.71%-4.22M
+69.89%-2.08M
+22.86%-5.22M
-36.42%-6.63M
+36.43%-4.62M
+25.00%-6.90M
+10.70%-6.77M
+21.43%-4.86M
-1.39%-7.27M
-0.41%-9.20M
-15.81%-7.58M
-39.55%-6.19M
-241.28%-7.17M
-8.80%-9.16M
-42.98%-6.55M
+11.86%-4.43M
+55.78%-2.10M
-88.89%-8.42M
-188.30%-4.58M
Net cash flow from continuing operations
+71.02%-1.92M
+8.71%-4.22M
+69.89%-2.08M
+22.86%-5.22M
-36.42%-6.63M
+36.43%-4.62M
+25.00%-6.90M
+10.70%-6.77M
+21.43%-4.86M
-1.39%-7.27M
-0.41%-9.20M
-15.81%-7.58M
-39.55%-6.19M
-241.28%-7.17M
-8.80%-9.16M
-42.98%-6.55M
+11.86%-4.43M
+55.78%-2.10M
-88.89%-8.42M
-188.30%-4.58M
Net Income from Continuing Operations
+21.10%-3.72M
+47.03%-3.12M
+50.39%-3.01M
+78.20%-1.83M
-18.18%-4.72M
+30.04%-5.89M
+28.47%-6.06M
+8.95%-8.40M
+21.96%-3.99M
-90.69%-8.41M
+30.60%-8.47M
-10.82%-9.22M
-48.40%-5.12M
-59.42%-4.41M
-119.16%-12.20M
-25.94%-8.32M
+17.91%-3.45M
+46.99%-2.77M
-8.34%-5.57M
-181.57%-6.61M
Gain/Loss from Continuing Operations
+260.93%2.90M
-1119.99%-365.45K
+55.21%-408.38K
-2128.55%-3.24M
-52.42%-1.80M
+266.39%35.83K
-70.87%-911.69K
-90.43%159.86K
+13.03%-1.18M
+99.03%-21.53K
-135.20%-533.56K
+66.47%1.67M
+11.01%-1.36M
+14.33%-2.23M
+14293.08%1.52M
+15751.40%1.00M
-6914.21%-1.53M
-4969.31%-2.60M
-175.63%-10.68K
+128.43%6.33K
Depreciation & Depletion & Amortization
-59.98%11.02K
-46.24%16.42K
-37.72%21.83K
-25.32%24.59K
+29.92%27.54K
+22.80%30.54K
+43.85%35.04K
+29.80%32.93K
-10.31%21.20K
+12.38%24.87K
-7.51%24.36K
+16.59%25.37K
+25.78%23.63K
+23.81%22.13K
+23.37%26.34K
+29.47%21.76K
+22.72%18.79K
+41.68%17.88K
+200.41%21.35K
+132.14%16.80K
Deferred Tax
+2647.28%191.40K
-13.80%-9.18K
+6.85%-8.34K
-11.78%-9.15K
+105.42%6.97K
---8.07K
---8.96K
---8.19K
---128.63K
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
Other Non-Cash Items
-90.97%84.16K
-34.91%254.13K
+26.64%573.14K
-22.82%686.17K
+153.97%932.51K
-1.03%390.46K
+3033.41%452.59K
+7982.15%889.03K
+2888.15%367.17K
+3195.20%394.54K
-172.03%-15.43K
-115.74%-11.28K
+22.35%-13.17K
-64.97%-12.75K
+26.48%-5.67K
-117.50%-5.23K
-67.60%-16.96K
+46.56%-7.73K
+25.34%-7.71K
+272.22%29.87K
Change in Working Capital
-11.13%-1.30M
-268.43%-1.20M
+211.14%577.06K
-216.79%-579.96K
-2960.79%-1.17M
+12.22%715.42K
-154.47%-519.21K
+487.32%496.59K
-121.46%-38.34K
+204.31%637.49K
-114.37%-204.04K
-118.36%-128.21K
-65.54%178.65K
-119.63%-611.14K
+148.64%1.42M
-63.80%698.14K
+141.85%518.44K
+699.19%3.11M
-555.49%-2.92M
+160.88%1.93M
-Change in Receivables
-118.91%-11.39K
+465.16%117.41K
-80.06%10.29K
-266.57%-134.99K
-94.89%60.26K
+113.48%20.78K
+107.10%51.59K
-46.73%-36.82K
+1137.84%1.18M
-210.74%-154.10K
-2568.82%-726.82K
-159.17%-25.10K
-163.45%-113.54K
-651.64%-49.59K
---27.23K
--42.41K
--178.93K
---6.60K
----
----
-Change in Prepaid Assets
+175.02%158.01K
-120.33%-24.14K
+11.11%360.33K
-349.54%-187.84K
+68.74%-210.63K
+147.47%118.71K
+250.39%324.30K
+1.62%75.28K
-684.59%-673.86K
+15.25%-250.07K
-50.58%92.56K
-4.59%74.08K
+53.65%115.27K
-167.44%-295.07K
--187.27K
--77.64K
--75.02K
--437.52K
----
----
-Change in Payables and Accrued Expense
-41.79%-1.45M
-325.42%-1.30M
+123.06%206.43K
-156.12%-257.12K
-88.46%-1.02M
-44.71%575.93K
-308.06%-895.11K
+358.55%458.14K
-406.83%-542.85K
+490.89%1.04M
-65.84%430.22K
-130.65%-177.19K
-33.11%176.92K
-109.93%-266.48K
--1.26M
--578.09K
--264.48K
--2.68M
----
----
Net cash flow from investing
-28683.06%-1.90M
+207.73%69.13K
-250.65%-19.68K
+100.00%0.00
+96.82%-6.60K
-438.45%-64.17K
+251.48%13.07K
-493.09%-44.34K
-1505.31%-207.46K
+257.47%18.96K
+107.17%3.72K
+115.74%11.28K
+101.31%14.76K
-221.97%-12.04K
-104.09%-51.82K
+100.39%5.23K
-21352.89%-1.13M
+85.31%-3.74K
+18246.86%1.27M
-10812.20%-1.33M
Net Cash Flow from Continuing Investing Activities
-28683.06%-1.90M
+207.73%69.13K
-250.65%-19.68K
+100.00%0.00
+96.82%-6.60K
-438.45%-64.17K
+251.48%13.07K
-493.09%-44.34K
-1505.31%-207.46K
+257.47%18.96K
+107.17%3.72K
+115.74%11.28K
+101.31%14.76K
-221.97%-12.04K
-104.09%-51.82K
+100.39%5.23K
---1.13M
---3.74K
+18246.86%1.27M
-10812.20%-1.33M
Net PPE Purchase and Sale
+96.57%-225.04
----
----
+100.00%0.00
+97.12%-6.56K
----
----
---74.26K
-16157.80%-227.94K
+99.34%-162.90
----
----
+121.03%1.42K
-211.30%-24.79K
----
----
---6.75K
---7.96K
+48.92%-10.05K
-631.43%-90.01K
Net Intangibles Purchase and Sale
-2279752.22%-1.90M
+99.55%-328.13
----
----
---83.37
---72.64K
----
----
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
---1.27M
Financing Cash Flow
+263.97%3.97M
+427.31%4.96M
-7550.19%-6.21M
-64.62%3.11M
+217.29%1.09M
-112.46%-1.52M
+4485.56%83.35K
--8.78M
-165.42%-928.96K
+1272.87%12.16M
-100.01%-1.90K
-100.00%0.00
+85.82%-349.99K
-101.97%-1.04M
+4702125.87%22.54M
+112.63%12.40K
-115.53%-2.47M
+4461.94%52.74M
-100.00%479.30
-106.32%-98.20K
Net Cash Flow from Continuing Financing Activities
+263.97%3.97M
+427.31%4.96M
-7550.19%-6.21M
-64.62%3.11M
+217.29%1.09M
-112.46%-1.52M
+4485.56%83.35K
--8.78M
-165.42%-928.96K
+1272.87%12.16M
-100.01%-1.90K
-100.00%0.00
+85.82%-349.99K
-101.97%-1.04M
+4702125.87%22.54M
+112.63%12.40K
---2.47M
--52.74M
-100.00%479.30
-106.32%-98.20K
Net Issuance Payments Of Debt
+3.02%-1.06M
---1.31M
---5.55M
---1.50M
-70.52%-1.09M
----
----
--0.00
---639.72K
----
----
----
----
----
----
----
----
----
----
----
Net Common Stock Issuance
----
+3887.08%7.22M
-155.92%-245.14K
-40.54%5.54M
--3.82M
---190.77K
--438.36K
--9.32M
+100.00%0.00
+100.00%0.00
--0.00
--0.00
+85.00%-413.15K
-101.96%-1.05M
----
----
---2.75M
--53.30M
----
----
Cash Dividends Paid
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
Proceeds from Stock Option Exercised
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-77.83%12.40K
----
----
----
--55.92K
Net Other Financing Charges
+89.22%-146.22K
-19107.62%-884.67K
-2895.09%-320.31K
-202.19%-686.88K
-1364775.86%-1.36M
+17706.75%4.65K
---10.69K
---227.30K
-97.11%99.37
-100.25%-26.43
----
----
-87.47%3.43K
+101.84%10.40K
----
----
--27.39K
---564.59K
--752.25
---154.13K
Ending Cash Balance
-64.36%5.48M
-74.15%5.36M
-83.86%4.43M
-60.77%13.27M
-51.73%15.37M
-46.64%20.72M
-17.93%27.46M
-21.13%33.83M
-37.35%31.84M
-31.91%38.84M
-49.20%33.46M
-16.41%42.89M
-11.73%50.82M
-12.35%57.03M
+383.92%65.87M
+145.54%51.31M
+114.11%57.58M
+306.34%65.07M
-30.66%13.61M
+95636.36%20.90M
Net Change in Cash
+102.58%143.05K
+113.10%811.93K
-22.08%-8.31M
-207.62%-2.12M
+7.50%-5.55M
-226.18%-6.20M
+26.03%-6.80M
+125.97%1.97M
+8.04%-6.00M
+159.80%4.91M
-169.05%-9.20M
-15.95%-7.57M
+18.80%-6.52M
-116.22%-8.21M
+286.16%13.32M
-8.65%-6.53M
-173.84%-8.03M
+1499.74%50.63M
-136.50%-7.16M
-13051.45%-6.01M
Beginning Cash Balance
-74.15%5.36M
-83.86%4.43M
-60.77%13.27M
-51.57%15.70M
-46.64%20.72M
-17.93%27.46M
-21.13%33.83M
-37.71%32.43M
-31.91%38.84M
-49.20%33.46M
-16.41%42.89M
-11.52%52.06M
-12.35%57.03M
+383.92%65.87M
+145.54%51.31M
+118.65%58.84M
+306.34%65.07M
-30.66%13.61M
+95636.36%20.90M
+39875.79%26.91M
Effect of Exchange Rate Changes
-84.97%26.48K
-207.14%-136.24K
+115.09%164.51K
+43.77%-316.44K
-89.54%176.13K
+151.20%127.16K
-299.57%-1.09M
+64.67%-562.79K
+27.18%1.68M
-111.11%-248.38K
+139.07%546.42K
-60.39%-1.59M
-11.21%1.32M
-11.12%2.24M
-586356.57%-1.40M
-269294.31%-993.23K
+1174126.87%1.49M
+232927.86%2.52M
-45.01%238.54
-270.91%-368.69
Free Cash Flow
+42.41%-3.82M
+10.11%-4.22M
+69.62%-2.10M
+23.70%-5.22M
-30.44%-6.64M
+35.43%-4.69M
+25.05%-6.90M
+9.72%-6.85M
+17.72%-5.09M
-1.04%-7.27M
+0.09%-9.21M
-15.81%-7.58M
-10.89%-6.18M
-241.17%-7.19M
-28.72%-9.22M
-10.27%-6.55M
-8.26%-5.58M
+55.31%-2.11M
-59.96%-7.16M
-270.94%-5.94M
Deadline
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018
Dec 31, 2017
Sep 30, 2017
Jun 30, 2017
Mar 31, 2017
Dec 31, 2016
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016
Dec 31, 2015
Sep 30, 2015
Jun 30, 2015
Mar 31, 2015
Dec 31, 2014
Sep 30, 2014
Jun 30, 2014
Mar 31, 2014
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2018/Q42018/Q32018/Q22018/Q12017/Q42017/Q32017/Q22017/Q12016/Q42016/Q32016/Q22016/Q12015/Q42015/Q32015/Q22015/Q12014/Q42014/Q32014/Q22014/Q1
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of de-escalation in U.S.-Iran military tensions have emerged, pushing international oil prices lower. Trump ordered the U.S. military Show More